SUMMARY |
|
1 | |
|
|
11 | |
|
|
11 | |
|
Committee Charge and Response, |
|
|
17 | |
|
2 TOXICOGENOMIC TECHNOLOGIES |
|
|
22 | |
|
|
24 | |
|
Transcriptomic Technologies, |
|
|
27 | |
|
|
34 | |
|
Metabolomic Technologies, |
|
|
41 | |
|
Technology Advancement and Economy of Scale, |
|
|
43 | |
|
3 EXPERIMENTAL DESIGN AND DATA ANALYSIS |
|
|
45 | |
|
|
45 | |
|
|
47 | |
|
Toxicogenomics and Biomarker Discovery, |
|
|
54 | |
|
|
56 | |
|
|
57 | |
|
4 APPLICATION TO EXPOSURE ASSESSMENT |
|
|
59 | |
|
Conventional Biomarkers of Exposure and Response, |
|
|
60 | |
|
State of the Art: Toxicogenomic Approaches to the Development of Exposure Biomarkers, |
|
|
61 | |
|
Evaluation of Exposure in Risk Assessment, |
|
|
67 | |
|
|
68 | |
|
|
71 | |
|
|
72 | |
|
5 APPLICATION TO HAZARD SCREENING |
|
|
73 | |
|
Description and Properties of Current Hazard Screening Methods, |
|
|
73 | |
|
In Vitro Versus In Vivo Testing, |
|
|
76 | |
|
Development of Predicitve Algorithms for Screening Purposes, |
|
|
77 | |
|
|
77 | |
|
|
83 | |
|
Challenges and Limitations, |
|
|
86 | |
|
|
89 | |
|
|
90 | |
|
6 APPLICATION TO ANALYZING VARIATION IN HUMAN SUSCEPTIBILITY |
|
|
92 | |
|
State of the Art in Assessment of Individual Variation, |
|
|
93 | |
|
|
100 | |
|
|
102 | |
|
|
103 | |
|
|
105 | |
|
7 APPLICATION TO THE STUDY OF MECHANISMS OF ACTION |
|
|
107 | |
|
State of the Art in Transcriptomics Analyses, |
|
|
108 | |
|
|
118 | |
|
|
119 | |
|
8 OTHER POTENTIAL APPLICATIONS OF TOXICOGENOMIC TECHNOLOGIES TO RISK ASSESSMENT |
|
|
121 | |
|
Potential Applications to Risk Assessment, |
|
|
121 | |
|
Implications for Better Use and Potential Reduction in the Use of Experimental Animals, |
|
|
131 | |
|
Implications of Toxicogenomics for Risk Assessment Infrastructure Needs, |
|
|
132 | |
|
|
133 | |
|
|
133 | |
|
|
135 | |
|
|
135 | |
|
|
149 | |
|
|
151 | |
10 SAMPLE AND DATA COLLECTION AND ANALYSIS |
|
152 | |
|
Leveraging Samples and Information in Population-Based Studies and Clinical Trials for Toxicogenomic Studies, |
|
|
152 | |
|
Existing Toxicogenomic Data Repositories: Standardization, Availability and Transparency, |
|
|
161 | |
|
|
166 | |
|
|
169 | |
11 ETHICAL, LEGAL, AND SOCIAL ISSUES |
|
172 | |
|
|
172 | |
|
Ethical and Social Issues, |
|
|
178 | |
|
|
186 | |
|
|
191 | |
|
Communication and Education, |
|
|
195 | |
|
Conclusions and Recommendations, |
|
|
197 | |
12 CONCLUSIONS AND RECOMMENDATIONS |
|
201 | |
|
A New Human Toxicogenomics Initiative, |
|
|
202 | |
|
|
203 | |
|
|
204 | |
|
|
205 | |
|
Variability in Susceptibility, |
|
|
206 | |
|
|
207 | |
|
Dose-response Relationships, |
|
|
208 | |
|
Cross-species Extrapolation, |
|
|
209 | |
|
|
209 | |
|
|
209 | |
|
|
210 | |
|
Ethical, Legal, and Social Issues, |
|
|
210 | |
|
Education and Training in Toxicogenomics, |
|
|
212 | |
REFERENCES |
|
213 | |
APPENDIXES |
|
|
A BIOGRAPHIC INFORMATION ON THE COMMITTEE ON APPLICATIONS OF TOXICOGENOMIC TECHNOLOGIES TO PREDICTIVE TOXICOLOGY |
|
|
255 | |
|
B MINIMUM INFORMATION ABOUT A MICROARRAY EXPERIMENT FOR TOXICOGENOMICS |
|
|
262 | |
|
C OVERVIEW OF RISK ASSESSMENT |
|
|
270 | |